| Tag | Content |
|---|
EnhancerAtlas ID | HS175-15352 |
Organism | Homo sapiens |
Tissue/cell | SK-N-MC |
Coordinate | chr2:152622330-152624770 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| Crx | MA0467.1 | chr2:152624597-152624608 | CTAATCCTCTT | - | 6.62 | | FOXC1 | MA0032.2 | chr2:152623111-152623122 | TAAGTAAACAT | + | 6.02 | | Foxa2 | MA0047.2 | chr2:152623109-152623121 | ACTAAGTAAACA | - | 6.44 |
|
| | Number of super-enhancer constituents: 4 | ID | Coordinate | Tissue/cell |
| SE_10660 | chr2:152620979-152629724 | CD19_Primary | | SE_11651 | chr2:152618651-152633942 | CD20 | | SE_40477 | chr2:152622452-152625492 | K562 | | SE_51329 | chr2:152622757-152625241 | Skeletal_Muscle |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr2 | 152622339 | 152623366 | | chr2 | 152623896 | 152624170 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH02I151765 | chr2 | 152622469 | 152624810 |
|
Enhancer Sequence | GAGATGGGAG GAGCAGTGTT TTAACCTGCT GCACATGGAC TGAAATACAG CTCTGAAGGC 60
GGAAATAAAA ACAAAGCCCT CCCATTAGAA TGAAATCCAA TCTCCTTGCC TCAGGCCCAC 120
TTCCTGCCCC TCCGTGCTCA GGCCACACTC TGGACTCACT GCCTCAAGTG CTTAAGCTCC 180
CTGCTCAAAC AGCGCCTGCC CATCGCTCTC CACGCCCCTG CCTCGCTGTA TTGCCGTATT 240
GCCTGCATGC TGCTCATCAC CTCTACCTTC CGTTGTAGAG CTGTCTATCT GGGTGTGACC 300
TGACCTCTCC CAGGGGGAAC GGGCTGCTAA GAGTTGGGAC TGCAGGGGCT TGTTTCATGC 360
TGTGAATTAG TTCCTGGCAT GCAGAAGGTA CACACAAAAA CAAATGAGAA CAGAAGTTTG 420
AGTAGCATAA TACACTAGAA ATTACTTCTT ATTTATGGTA TTCATTTTAG ACATGGAGAA 480
AATGAGGCCT AGAAAGGTTA GAGTGGCTTC CCCAAAGCCA CATGACCAGG GAGCAGTGGG 540
GTCAGGCCTA GAAGTCCAGG GGTCCTGATT CTTCCAGACT GGTGTTCATC CAAACACCCC 600
ACCCTCACCC ACAGTGGCCT TTGGTGTGTT CTCTCTGTGT CTCTCTCATG CACACACACA 660
CACACACACA CACTCCTTCT AATGGGCCAC AAGGGAAATC TCAAGTAAAT GATATTCAGT 720
AGTAGTTTCC TGCCCCAACA TTCAAAATTT GAGCCAAGAG AGAAAGGAAG TTGAGAGCTA 780
CTAAGTAAAC ATTTAAAGCC TACAAGGCAG AGATCTTCTC CAAATTTGAC AGATAAAGCA 840
CTGGGCCTTG AAGAAGCAGA GAAGGTAAGA GGCTTTGCTC AGTAGCTCCA CCAACAAGCT 900
GCGTTGCTGA CTCAGAGCCC TTTGTCATAA CAGCACTGCT GGGCCCCTCA TTAGACTGCC 960
TGCACCAAGG CTGAGGTCTC CTGTTGGTTG TCCCCATCTC TGGTGGATGC CCTTGTGACT 1020
GCATGACCTA CAGTCTCTCA AGTTCTTAAC AAGCCACATC GGCTTTGGGG CAGCAGCCCT 1080
ACCTTTGATT CAGAGCTTAG GGTGTGTGCC TTCGAGGCTG AGAGGAGTGT GCAGGCATAG 1140
CTGGCACTTT CTAGAATGAC AGCTCATCTG CCTGCCCACC CCCCCGTGAA GGTGCCAGGG 1200
ACTGAGATAA CCCAAAGGCA CTCACCCTCC CAGGAGTACC TCTCATCCTC CCCTGTGCAT 1260
TAGCTCCTAG GGTCAGTGGA TGCTCCCAGC TAGAGATTAC TGGGCAAAGC CACCTTTAAA 1320
ATGAACAAAC TTGCACATAT AGTTCCCCCA GCTACTCAGG AGGCTGACGC AGGAGGATCA 1380
CTTGAACCCA GGAGTTGGAG TCCAGCATGG GCAACATGGC AGGTGAGACC CCCATCTCTA 1440
AAAAACAAAA AAGAAAAGAA AAATCAATGA GCCCAGCTAG CACTTAGCAA GTGTGGGCAT 1500
AAACATGCAT GTTCAATGTT CAAGCACCAG AGGACACACA CGAACACCCC TCACAGTTTT 1560
ATTTTAGGTC AGAAGTAGGC AACCTTAGAG TTGGAACTTG GAAACAGGCA TATGTTAGTG 1620
TCATACAGAG GACAGATGAG ACAGAATCTG AGGGCCTCCA CAGGGCAGAA TGAGGCTTAA 1680
GAGAGTTCCA GGGAAGTTAA TACAGAGAAA GACTTCCTAA CAACTAGAGC TGCCTGAAAA 1740
AGCAGCAGCC TGTCTGGCAC GGCAGTGGCT GCTGTGGCTC AAAGGGTATG GAACATGAAT 1800
GCACAGCCCC TGAGTAGAAA CGCTGAGGGG ACTTCAGCCT CCAGGATCCT TCCAACACTA 1860
AGACTCTGAG ACATCTTGAA ATAGTTCACT TACTGCTGTC TGGTGTCAAA TCATCATTTC 1920
CTAAAGTCAC TATGACTCAT GGTTCCTGAG GACAACTTTT GTCCCCATAT CCCAGAGGTA 1980
TTCACTTTGA AGTTTTAAGA AAGAAGACAA ACTTGTAAGC AGGGAGTTTG TGTTTGGCTG 2040
TCAGTGATAA CTTACAGATA TTTCTCATCT CCCTCTCCCT GTGATATATT TTAAAAGTAT 2100
ATTACTATAG GGAGTATACT TGGAGGAAAC TGTCAAAACG TCTTCAAAAC CCAAGGAGTT 2160
AAAATTGATG TCCTGCTTTC AGAAACAGCC AGGTAAATCC TTCCATTGAC TAAAACTCTC 2220
TGCTCAGCAC CCTCACTCAA CTGTCTGGGA GCAATAAGGA GGACTTGCTA ATCCTCTTCA 2280
AGGAGCAGAG AAATATTTGC CATTACACTT GTGAGCCTGC CATGTGACCC TGGGAAAGCT 2340
GCTTAGCTTC TCTGAGCCTC AGTTTCCTCA TGTGAAATGT GGAGGTTAGA CTAGTGCCTA 2400
CTGTACAGAG TTACTGGTAG CATTAAATTA AATAATGCAT 2440
|
